
SF Healthcare Week: Baird Senior Analyst Brian Skorney comments on Monday's conference news and highlights his top picks ahead for 2026
BiotechTV - News
00:00
Xenon KV7 Program Importance
Brad shifts to Xenon; Brian outlines azetocolinum's KV7 mechanism and upcoming March efficacy readout.
Play episode from 03:52
Transcript


